Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $33.40M in the twelve months ending March 31, 2024, with 127.41% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.43M, a -30.64% decrease year-over-year. In the year 2023, Caribou Biosciences had annual revenue of $34.48M with 148.91% growth.

• Revenue (ttm): $33.40M
• Revenue Growth: +127.41%
• P/S Ratio: 9.19
• Revenue / Employee: $211,418
• Employees: 158
• Market Cap: 307.07M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.48M	20.63M	148.91%
Dec 31, 2022	13.85M	4.25M	44.31%
Dec 31, 2021	9.60M	-2.76M	-22.35%
Dec 31, 2020	12.36M	6.57M	113.56%
Dec 31, 2019	5.79M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.